换一批Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death.
第一作者：
Cecilia T,Costiniuk
第一单位：
Department of Internal Medicine, University of Ottawa, Canada.
作者：
医学主题词
成年人(Adult);贫血(Anemia);抗病毒药(Antiviral Agents);心血管疾病(Cardiovascular Diseases);女(雌)性(Female);补血药(Hematinics);血红蛋白类(Hemoglobins);丙型肝炎(Hepatitis C);人类(Humans);干扰素类(Interferons);Logistic模型(Logistic Models);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);肿瘤(Neoplasms);回顾性研究(Retrospective Studies);利巴韦林(Ribavirin);治疗结果(Treatment Outcome)
DOI
10.1086/589243
PMID
18532889
发布时间
2013-11-21
- 浏览16
Clinical infectious diseases
198-202页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
